HOME >> BIOLOGY >> NEWS
A New Look At Margerine And Health

Margarines are a healthy choice according to a CSIRO study.

The study, published recently in the American Journal of Clinical Nutrition, indicated that the benefits of polyunsaturated margarines are enhanced when they are also low in trans fatty acids, substances which raise total blood cholesterol.

Clinical trials conducted at CSIRO Human Nutrition in Adelaide, compared the effects of four types of margarine on blood cholesterol. The margarines were polyunsaturated or monounsaturated, with or without trans fatty acids. Thirty eight men and women with mildly elevated cholesterol took part in the feeding trial, lasting 11 weeks.

The results of the study showed that, compared to saturated fat spreads, any of the four margarines reduced the level of LDL (bad) cholesterol in the blood by 11 - 15 per cent. This corresponds to a fall in the risk of heart disease of approximately 20 - 30 per cent. HDL (good) cholesterol was unchanged. In an unexpected finding, the margarine high in polyunsaturates and low in trans fatty acids produced a greater fall in blood LDL-cholesterol than the other margarines.

"The margarine high in polyunsaturates and low in trans fatty acid lowered LDL-cholesterol a further 6 per cent compared to other margarines, a statistically significant difference", said CSIRO researcher Manny Noakes.

"Based on our data, the fall in heart disease risk could be reckoned to be 13 per cent greater with the polyunsaturated margarine without trans fatty acids than a similar spread with trans fatty acids."

Trans fatty acids are a minor class of fats found in small quantities in certain animal products. They used to be present in moderate quantities in margarines. However, there has been an international trend to reduce levels of trans fatty acids in margarines.

Approximately half the margarines on the Australian market do not contain trans fatty acids.

More information:
Manny Noakes, CSIRO, 08-83038827 or
Jenny Rhodes,
'"/>

Contact: Rosie Schmedding
rosie.schmedding@nap.csiro.au
61-2-6276-6520
CSIRO Australia
27-Nov-1998


Page: 1 2

Related biology news :

1. Health of worlds sea lions the focus of Wakefield Symposium
2. OneWorld Health compiles comprehensive state of infectious diarrhea treatments, potential solutions
3. Institute for OneWorld Health nominated for the 2004 World Technology Awards
4. Healthy fats and oils essential to satisfy calorie-conscious consumers
5. Institute for OneWorld Health receives Gates Foundation grant
6. Donaghue Womens Health Investigator Program awards grants to three at Yale
7. OneWorld Health CEO outlines mutually beneficial collaborations between industry, nonprofits at BIO
8. Addressing the Healthcare Needs of Our Aging Population with Technology
9. Institute for OneWorld Health CEO to speak at BIO on leveraging opportunities for global health
10. OneWorld Health completes enrollment, treatment in Phase III India trial
11. Institute for OneWorld Health CEO advocates focus first on developing world markets

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New Look Margerine And Health

(Date:10/15/2014)... the 44th Rosenstiel Award for Distinguished Work in Biomedical ... the mechanisms of genomic instability and its implications for ... second alumnus to win the Rosenstiel Award; the first, ... Alt is the Charles A. Janeway Professor of Pediatrics ... an investigator at the Howard Hughes Medical Institute at ...
(Date:10/14/2014)... shows SIRT6—a protein known to inhibit the growth ... skin cancers by turning on an enzyme that increases ... Previously considered protective, SIRT6 is part of a family ... stability and prevent some of the genetic flaws associated ... lead to cancer. This study, in the journal,s October ...
(Date:10/14/2014)... of the planet,s leading questions is how to produce ... variable climate. The Food and Agriculture Organization of the ... over the next 40 years to feed a growing ... the necessary rise in food production. Plants—grains, cereals, ... supporting livestock. Current research must tap into our ...
Breaking Biology News(10 mins):Brandeis awards 44th Rosenstiel Award to pioneering geneticist Fred Alt 2Two-faced gene: SIRT6 prevents some cancers but promotes sun-induced skin cancer 2Building a bridge from basic botany to applied agriculture 2Building a bridge from basic botany to applied agriculture 3
(Date:10/22/2014)... YORK , Oct. 22, 2014 Nuvilex, ... Federation, approximately 400 million people worldwide are living with ... million people by 2030.  The global market for diabetes ... 2012 approximately 330,000 people worldwide died from pancreatic cancer.  ... death due to cancer in the United ...
(Date:10/22/2014)... and HONG KONG , Oct. ... disease therapeutics enterprise, announced today that rare disease expert ... as vice president, research. Dr. McKew brings more than ... leadership positions at the National Institutes of Health, Wyeth ... by Wyeth). Dr. McKew will lead aTyr,s efforts to expand ...
(Date:10/20/2014)... YORK , Oct. 20, 2014 ... their experimental ZMapp™ antibody therapeutic to fight the ... how difficult and time-consuming the production of pharmaceuticals ... market research publisher said that while some may ... of this compound, those with industry knowledge are ...
(Date:10/20/2014)... , Oct. 20, 2014 Asterias ... the Company has signed a Notice of Grant ... Medicine (CIRM), effective October 1, 2014.  The NGA ... payments and the release of additional grant funds ... grant award for clinical development of Asterias, product, ...
Breaking Biology Technology:Nuvilex Brief Analyst Report: Thinking Outside the Box by BrokerBank Securities, Inc. 2aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 2aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 3Kalorama: ZMapp Highlights Need For Faster Biopharmaceutical Production 2Kalorama: ZMapp Highlights Need For Faster Biopharmaceutical Production 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 4
Cached News: